TRIPLE MARKER TEST
Test is valid between 14-22 weeks gestation (Ideal 15-2 weeks). Provide maternal Date of birth (dd/mm/yy); LMP or Ultrasound; IVF, Number of Fetuses (Single/ Twins); Diabetic status and Body Weight in Kg, Smoking & Previous history of Trisomy 21
The Triple marker test, also known as the multiple marker screening tests, is a blood test that screens for the risk of certain foetal abnormalities in pregnant mothers. The test measures the levels of three substances in the mother's blood: human chorionic gonadotropin (HCG), alpha-fetoprotein (AFP), and estriol. These substances are produced by the foetus and pass through the placenta into the mother's bloodstream. Abnormal levels of these substances can indicate the risk of chromosomal abnormalities, neural tube defects, and other congenital disabilities in the developing foetus. The test is typically performed between the 15th and 20th week of pregnancy and is non-invasive, meaning it does not pose a risk to the mother or foetus.
Frequently asked questions
Yes, medications or supplements can affect Triple Marker Test results. Certain medications or supplements can cause elevated or decreased levels of the substances measured in the test, which can lead to false positive or false negative results. It is important to inform your healthcare provider if you take any medications or supplements before the test.
There is no specific preparation required for a Triple Marker Test. However, pregnant women should inform their healthcare provider of any medications or supplements they are taking before undergoing the test, as these can affect the test results.
The turnaround time for Triple Marker Test results varies depending on the testing facility and location. In general, it can take anywhere from a few days to a week to receive the results. Your healthcare provider can provide you with a more specific period based on the testing facility used.
The Triple Marker Test is a simple blood test and is not painful. It also carries no significant risk to the mother or foetus, making it a safe prenatal screening test.